Different antiviral effects of IFNα subtypes in a mouse model of HBV infection

Abstract Interferon alpha (IFNα) is commonly used for the treatment of chronic hepatitis B (CHB) patients. There are 13 different IFNα subtypes in humans, but only the subtype IFNα2 is used for clinical treatment. The antiviral activities of all other IFNα subtypes against HBV have not been studied....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingjiao Song, Sheng Li, Yun Zhou, Jia Liu, Sandra Francois, Mengji Lu, Dongliang Yang, Ulf Dittmer, Kathrin Sutter
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/23174242175f492487c0baadadc7baf5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23174242175f492487c0baadadc7baf5
record_format dspace
spelling oai:doaj.org-article:23174242175f492487c0baadadc7baf52021-12-02T12:30:19ZDifferent antiviral effects of IFNα subtypes in a mouse model of HBV infection10.1038/s41598-017-00469-12045-2322https://doaj.org/article/23174242175f492487c0baadadc7baf52017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00469-1https://doaj.org/toc/2045-2322Abstract Interferon alpha (IFNα) is commonly used for the treatment of chronic hepatitis B (CHB) patients. There are 13 different IFNα subtypes in humans, but only the subtype IFNα2 is used for clinical treatment. The antiviral activities of all other IFNα subtypes against HBV have not been studied. To obtain basic knowledge about the direct antiviral as well as the immunomodulatory effects of IFNα subtypes, we used the HBV hydrodynamic injection (HI) mouse model. Application of most IFNα subtype proteins inhibited HBV replication in vivo, with IFNα4 and IFNα5 being the most effective subtypes. Decreased viral loads after therapeutic application of IFNα4 and IFNα5 correlated with expanded effector cell populations of NK cells and T cells in both liver and spleen. Hydrodynamic injection of plasmids encoding for the effective IFNα subtypes (pIFNα) was even more potent against HBV than injecting IFNα proteins. The combination of pIFNα4 and pIFNα5 showed a synergistic antiviral effect on HBV replication, with a strong increase in NK cell and T cell activity. The results demonstrate distinct anti-HBV effects of different IFNα subtypes against HBV in the mouse model, which may be relevant for new therapeutic approaches.Jingjiao SongSheng LiYun ZhouJia LiuSandra FrancoisMengji LuDongliang YangUlf DittmerKathrin SutterNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jingjiao Song
Sheng Li
Yun Zhou
Jia Liu
Sandra Francois
Mengji Lu
Dongliang Yang
Ulf Dittmer
Kathrin Sutter
Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
description Abstract Interferon alpha (IFNα) is commonly used for the treatment of chronic hepatitis B (CHB) patients. There are 13 different IFNα subtypes in humans, but only the subtype IFNα2 is used for clinical treatment. The antiviral activities of all other IFNα subtypes against HBV have not been studied. To obtain basic knowledge about the direct antiviral as well as the immunomodulatory effects of IFNα subtypes, we used the HBV hydrodynamic injection (HI) mouse model. Application of most IFNα subtype proteins inhibited HBV replication in vivo, with IFNα4 and IFNα5 being the most effective subtypes. Decreased viral loads after therapeutic application of IFNα4 and IFNα5 correlated with expanded effector cell populations of NK cells and T cells in both liver and spleen. Hydrodynamic injection of plasmids encoding for the effective IFNα subtypes (pIFNα) was even more potent against HBV than injecting IFNα proteins. The combination of pIFNα4 and pIFNα5 showed a synergistic antiviral effect on HBV replication, with a strong increase in NK cell and T cell activity. The results demonstrate distinct anti-HBV effects of different IFNα subtypes against HBV in the mouse model, which may be relevant for new therapeutic approaches.
format article
author Jingjiao Song
Sheng Li
Yun Zhou
Jia Liu
Sandra Francois
Mengji Lu
Dongliang Yang
Ulf Dittmer
Kathrin Sutter
author_facet Jingjiao Song
Sheng Li
Yun Zhou
Jia Liu
Sandra Francois
Mengji Lu
Dongliang Yang
Ulf Dittmer
Kathrin Sutter
author_sort Jingjiao Song
title Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
title_short Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
title_full Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
title_fullStr Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
title_full_unstemmed Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
title_sort different antiviral effects of ifnα subtypes in a mouse model of hbv infection
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/23174242175f492487c0baadadc7baf5
work_keys_str_mv AT jingjiaosong differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT shengli differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT yunzhou differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT jialiu differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT sandrafrancois differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT mengjilu differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT dongliangyang differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT ulfdittmer differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
AT kathrinsutter differentantiviraleffectsofifnasubtypesinamousemodelofhbvinfection
_version_ 1718394385289183232